
NEJM Interview: Dr. Joseph Ross on shifts in the FDA’s use of accelerated approval and associated challenges for clinicians and patients.
NEJM Interviews
00:00
The Importance of Patient Education in FDA Approval
Clinicians are going to need to help patients and caregivers make individual decisions about using drugs that are granted this accelerated approval. Some of that will involve actually having a more nuanced understanding of the evidence that supported FDA approval. When products come through the accelerated approval pathway, because the trials tend to be smaller and shorter, we often know less about safety as well.
Transcript
Play full episode